Versant Capital Management, Inc Neogenomics Inc Call Options Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NEO
# of Institutions
292Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$361 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$258 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$126 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$121 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$120 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.31B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...